Aclaris Therapeutics Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Weaker technical forecast for Aclaris Therapeutics as stock downgraded to Sell Candidate.
(Updated on Apr 19, 2024)
The Aclaris Therapeutics stock price gained 0.81% on the last trading day (Friday, 19th Apr 2024), rising from $1.23 to $1.24. During the last trading day the stock fluctuated 3.31% from a day low at $1.21 to a day high of $1.25. The price has risen in 4 of the last 10 days and is up by 4.2% over the past 2 weeks. Volume fell on the last day by -66 thousand shares and in total, 570 thousand shares were bought and sold for approximately $707.21 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Aclaris Therapeutics stock with a 90% probability to be traded between $1.07 and $1.45 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ACRS Signals & Forecast
The Aclaris Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.22 and $1.23. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -1.59%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Aclaris Therapeutics stock
Aclaris Therapeutics finds support from accumulated volume at $1.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 3.31%. For the last week the stock has had daily average volatility of 4.32%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ACRS) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Aclaris Therapeutics to open at $1.23, and during the day (based on 14 day Average True Range), to move between $1.17 and $1.31, which gives a possible trading interval of +/-$0.0686 (+/-5.53%) up or down from last closing price. If Aclaris Therapeutics takes out the full calculated possible swing range there will be an estimated 11.07% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.25 (0.81%) than the support at $1.23 (0.81%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Aclaris Therapeutics stock A Buy?
Aclaris Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -1.044 Sell Candidate Downgraded
Predicted Opening Price for Aclaris Therapeutics of Monday, April 22, 2024
| Fair opening price April 22, 2024 | Current price |
|---|---|
| $1.23 ( 0.538%) | $1.24 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ACRS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.27 | 2.69 % | |
| R2 | 1.26 | 1.46 % | ||
| R1 | 1.25 | 0.695 % | ||
| Current price: | 1.24 | |||
| Support | S1 | 1.22 | -1.77 % | |
| S2 | 1.21 | -2.53 % | ||
| S3 | 1.19 | -3.76 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.28 | 3.23 % | |
| R2 | 1.26 | 1.61 % | ||
| R1 | 1.25 | 0.81 % | ||
| Current price | 1.24 | |||
| Support | S1 | 1.23 | -0.81% | |
| S2 | 1.21 | -2.42% | ||
| S3 | 1.19 | -4.03% |
FAQ
Click here for our free guide on how to buy Aclaris Therapeutics Stock.
